Please use this identifier to cite or link to this item:
https://olympias.lib.uoi.gr/jspui/handle/123456789/19507Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Kalogeraki, A. | en |
| dc.contributor.author | Panayiotides, J. | en |
| dc.contributor.author | Tamiolakis, D. | en |
| dc.contributor.author | Tzardi, M. | en |
| dc.contributor.author | Chaniotis, V. | en |
| dc.contributor.author | Chalkiadakis, G. | en |
| dc.contributor.author | Melissas, J. | en |
| dc.contributor.author | Stiftsis, D. | en |
| dc.contributor.author | Kanavaros, P. | en |
| dc.contributor.author | Delides, G. S. | en |
| dc.date.accessioned | 2015-11-24T19:00:18Z | - |
| dc.date.available | 2015-11-24T19:00:18Z | - |
| dc.identifier.issn | 0250-7005 | - |
| dc.identifier.uri | https://olympias.lib.uoi.gr/jspui/handle/123456789/19507 | - |
| dc.rights | Default Licence | - |
| dc.subject | Biopsy, Needle | en |
| dc.subject | Breast Diseases/metabolism/pathology | en |
| dc.subject | Breast Neoplasms/*metabolism/pathology | en |
| dc.subject | Carcinoma, Ductal, Breast/*metabolism/pathology | en |
| dc.subject | Female | en |
| dc.subject | Fibroadenoma/*metabolism/pathology | en |
| dc.subject | Humans | en |
| dc.subject | Neoplasm Invasiveness | en |
| dc.subject | Tumor Suppressor Protein p53/*biosynthesis/immunology | en |
| dc.title | P53 expression in patients with malignant and benign breast diseases | en |
| heal.type | journalArticle | - |
| heal.type.en | Journal article | en |
| heal.type.el | Άρθρο Περιοδικού | el |
| heal.identifier.secondary | http://www.ncbi.nlm.nih.gov/pubmed/10928110 | - |
| heal.language | en | - |
| heal.access | campus | - |
| heal.recordProvider | Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής | el |
| heal.publicationDate | 2000 | - |
| heal.abstract | Immunohistochemical expression of p53 protein was studied in FNA specimens of 20 breast ductal carcinomas, 20 fibroadenomas and 20 atypical ductal hyperplasia of the breast. Nine cases of breast carcinomas (45%), five fibroadenomas (25%) and four atypical ductal hyperplasia (20%) were found to be p53-immuno-positive. A statistically significant difference was found among p53 staining index of breast carcinomas (mean 72.55%), fibroadenomas (mean 41.2%) and atypical ductal hyperplasia (mean 34%). Variations in p53 expression among individual breast carcinomas was found, and these variations may correlate with prognosis. | en |
| heal.journalName | Anticancer Res | en |
| heal.journalType | peer-reviewed | - |
| heal.fullTextAvailability | TRUE | - |
| Appears in Collections: | Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ | |
Files in This Item:
There are no files associated with this item.
This item is licensed under a Creative Commons License
